← Scoopfeeds — Intelligent news, curated.
Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in Advanced NSCLC
business

Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in Advanced NSCLC

Yahoo Finance · Jun 4, 2026, 9:05 AM · Also reported by 1 other source

Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in Advanced NSCLC

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Edesa reports exploratory data on AKI treatment candidate

More in business

BBC Business
Free Thinking
Decrypt
Zcash Bug Crisis Shows Privacy Cuts Both Ways, Experts Say
Bloomberg Markets
Earnings and AI-Driven CapEx as Key to Sustained Gains
Investing.com
Tigo Energy CEO Alon Zvi sells $246,434 in common stock
Investing.com
S&P Global affirms Sweden’s AAA rating on defense spending, growth
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop